{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T22:36:00Z","timestamp":1788561360510,"version":"build-2803163510"},"reference-count":33,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2015,11,4]],"date-time":"2015-11-04T00:00:00Z","timestamp":1446595200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>BACKGROUND<\/jats:title>\n                  <jats:p>Functional status may be useful for identifying older adults who benefit from lower blood pressure. We examined whether functional status modifies the effect of antihypertensive treatment among older adults.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>METHODS<\/jats:title>\n                  <jats:p>Post hoc analyses of the Systolic Hypertension in the Elderly Program (SHEP), a randomized trial of antihypertensive therapy vs. placebo (1985\u20131991) in 4,736 adults aged 60 years or older with isolated systolic hypertension. Outcomes were all-cause death, cardiovascular (CV) death, myocardial infarction (MI), stroke, falls, and symptoms of hypotension. The effect modifier of interest was functional status, assessed by self-reported physical ability limitation (PAL).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS<\/jats:title>\n                  <jats:p>Among persons with no PAL, those receiving treatment had a lower rate of death, CV death, and MI compared with placebo (4.0, 2.9, and 4.2 per 1,000 person-years lower, respectively). In contrast, among persons with a PAL, those receiving treatment had a higher rate of death, CV death, and MI compared with placebo (8.6, 5.3, and 2.7 per 1,000 person-years higher, respectively). These patterns persisted in Cox models, although interaction terms did not reach statistical significance. Treatment remained protective for stroke regardless of functional status. The rate of falls associated with treatment differed by functional status; incidence-rate ratio = 0.81, 95% confidence interval (CI) = (0.66, 0.99), and 1.32, 95% CI = (0.87, 2.00) in participants without and with a PAL, respectively, in models adjusted for demographics and baseline blood pressure ( P -value for interaction, 0.04).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS<\/jats:title>\n                  <jats:p>Functional status may modify the effect of antihypertensive treatment on MI, mortality, and falls, but not stroke, in older adults. Functional status should be examined in other trial settings.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ajh\/hpv177","type":"journal-article","created":{"date-parts":[[2015,11,6]],"date-time":"2015-11-06T01:43:47Z","timestamp":1446774227000},"page":"690-695","source":"Crossref","is-referenced-by-count":42,"title":["Functional Status and Antihypertensive Therapy in Older Adults: A New Perspective on Old Data"],"prefix":"10.1093","volume":"29","author":[{"given":"Christina J.","family":"Charlesworth","sequence":"first","affiliation":[{"name":"College of Public Health & Human Sciences, Oregon State University 1 , Corvallis, Oregon , USA ;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen A.","family":"Peralta","sequence":"additional","affiliation":[{"name":"School of Medicine, University of California San Francisco 2 , San Francisco, California , USA ."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle C.","family":"Odden","sequence":"additional","affiliation":[{"name":"College of Public Health & Human Sciences, Oregon State University 1 , Corvallis, Oregon , USA ;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2015,11,4]]},"reference":[{"key":"2024012523124504800_CIT0001","doi-asserted-by":"crossref","DOI":"10.1093\/gerona\/glv013","article-title":"Polypharmacy Among Adults Aged 65 Years and Older in the United States: 1988\u20132010","author":"Charlesworth","year":"2015","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"2024012523124504800_CIT0002","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1097\/HJH.0b013e328339f9c5","article-title":"Treatment of hypertension in patients 80 years and older: the lower the better? A meta-analysis of randomized controlled trials","volume":"28","author":"Bejan-Angoulvant","year":"2010","journal-title":"J Hypertens"},{"key":"2024012523124504800_CIT0003","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1136\/bmj.316.7147.1780","article-title":"Blood pressure and mortality in elderly people aged 85 and older: community based study","volume":"316","author":"Boshuizen","year":"1998","journal-title":"Br Med J"},{"key":"2024012523124504800_CIT0004","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1093\/oxfordjournals.eurheartj.a015360","article-title":"Blood pressure and mortality in an older population. A 5-year follow-up of the Helsinki Ageing Study","volume":"18","author":"Hakala","year":"1997","journal-title":"Eur Heart J"},{"key":"2024012523124504800_CIT0005","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1111\/j.1532-5415.2006.00742.x","article-title":"Association between blood pressure and survival over 9 years in a general population aged 85 and older","volume":"54","author":"Rastas","year":"2006","journal-title":"J Am Geriatr Soc"},{"key":"2024012523124504800_CIT0006","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1046\/j.1532-5415.2001.49078.x","article-title":"The relationship between blood pressure and mortality in the oldest old","volume":"49","author":"Satish","year":"2001","journal-title":"J Am Geriatr Soc"},{"key":"2024012523124504800_CIT0007","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1136\/bmj.296.6626.887","article-title":"Blood-pressure and 5-year survival in the very old","volume":"296","author":"Mattila","year":"1988","journal-title":"Br Med J"},{"key":"2024012523124504800_CIT0008","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1093\/eurjhf\/hfs203","article-title":"Low blood pressure predicts increased mortality in very old age even without heart failure: the Leiden 85-plus Study","volume":"15","author":"Poortvliet","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"2024012523124504800_CIT0009","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1001\/jama.2013.284427","article-title":"2014 Evidence-based guideline for the management of high blood pressure in adults report from the panel members appointed to the Eighth Joint National Committee (JNC 8)","volume":"311","author":"James","year":"2014","journal-title":"JAMA"},{"key":"2024012523124504800_CIT0010","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1001\/jama.2014.440","article-title":"Groups spar over new hypertension guidelines","volume":"311","author":"Mitka","year":"2014","journal-title":"JAMA"},{"key":"2024012523124504800_CIT0011","doi-asserted-by":"crossref","first-page":"499","DOI":"10.7326\/M13-2981","article-title":"Evidence supporting a systolic blood pressure goal of less than 150mm Hg in patients aged 60 years or older: the minority view","volume":"160","author":"Wright","year":"2014","journal-title":"Ann Intern Med"},{"key":"2024012523124504800_CIT0012","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1093\/gerona\/glr245","article-title":"The association of blood pressure and mortality differs by self-reported walking speed in older Latinos","volume":"67","author":"Odden","year":"2012","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"2024012523124504800_CIT0013","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1001\/archinternmed.2012.2555","article-title":"Rethinking the association of high blood pressure with mortality in elderly adults: the impact of frailty","volume":"172","author":"Odden","year":"2012","journal-title":"Arch Intern Med"},{"key":"2024012523124504800_CIT0014","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1161\/HYPERTENSIONAHA.114.03831","article-title":"Systolic and diastolic blood pressure, incident cardiovascular events, and death in elderly persons: the role of functional limitation in the Cardiovascular Health Study","volume":"64","author":"Peralta","year":"2014","journal-title":"Hypertension"},{"key":"2024012523124504800_CIT0015","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.1001\/jama.1991.03460240051027","article-title":"Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension - final results of the Systolic Hypertension in the Elderly Program (SHEP)","volume":"265","author":"Probstfield","year":"1991","journal-title":"JAMA"},{"key":"2024012523124504800_CIT0016","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/0895-4356(88)90024-8","article-title":"Rationale and design of a randomized clinical trial on prevention of stroke in isolated systolic hypertension","volume":"41","author":"Probstfield","year":"1988","journal-title":"J Clin Epidemiol"},{"key":"2024012523124504800_CIT0017","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1161\/STROKEAHA.112.663062","article-title":"High blood pressure, physical and cognitive function, and risk of stroke in the oldest old The Leiden 85-Plus Study","volume":"44","author":"Sabayan","year":"2013","journal-title":"Stroke"},{"key":"2024012523124504800_CIT0018","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s12916-015-0328-1","article-title":"No evidence that frailty modifies the positive impact of antihypertensive treatment in very elderly people: an investigation of the impact of frailty upon treatment effect in the HYpertension in the Very Elderly Trial (HYVET) study, a double-blind, placebo-controlled study of antihypertensives in people with hypertension aged 80 and over","volume":"13","author":"Warwick","year":"2015","journal-title":"BMC Med"},{"key":"2024012523124504800_CIT0019","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1001\/jamainternmed.2013.2542","article-title":"Walking speed is a useful marker of frailty in older persons - reply","volume":"173","author":"Odden","year":"2013","journal-title":"JAMA Intern Med"},{"key":"2024012523124504800_CIT0020","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s11906-013-0402-z","article-title":"Blood pressure levels and stroke: J-curve phenomenon?","volume":"15","author":"Malyszko","year":"2013","journal-title":"Curr Hypertens Rep"},{"key":"2024012523124504800_CIT0021","doi-asserted-by":"crossref","first-page":"884","DOI":"10.7326\/0003-4819-144-12-200606200-00005","article-title":"Dogma disputed: Can aggressively hypertensive patients with coronary artery lowering blood pressure in disease be dangerous?","volume":"144","author":"Messerli","year":"2006","journal-title":"Ann Intern Med"},{"key":"2024012523124504800_CIT0022","article-title":"Landmark NIH study shows intensive blood pressure management may save lives [press release]","year":"2015"},{"key":"2024012523124504800_CIT0023","doi-asserted-by":"crossref","DOI":"10.1001\/jamainternmed.2015.4103","article-title":"Effect of Discontinuation of Antihypertensive Treatment in Elderly People on Cognitive Functioning\u2014the DANTE Study Leiden: a randomized clinical trial","author":"Moonen","year":"2015","journal-title":"JAMA Intern Med"},{"key":"2024012523124504800_CIT0024","doi-asserted-by":"crossref","DOI":"10.1001\/jamainternmed.2015.4309","article-title":"A discontinuation trial of antihypertensive treatment: the other side of the story","author":"Odden","year":"2015","journal-title":"JAMA Intern Med"},{"key":"2024012523124504800_CIT0025","doi-asserted-by":"crossref","first-page":"M217","DOI":"10.1093\/gerona\/56.4.M217","article-title":"Hypertension in older adults","volume":"56","author":"Rigaud","year":"2001","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"2024012523124504800_CIT0026","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1161\/HYPERTENSIONAHA.113.00911","article-title":"Treatment of hypertension in the oldest old: a critical role for frailty?","volume":"63","author":"Muller","year":"2014","journal-title":"Hypertension"},{"key":"2024012523124504800_CIT0027","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1093\/gerona\/58.7.M653","article-title":"Embracing complexity: A consideration of hypertension in the very old","volume":"58","author":"Goodwin","year":"2003","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"2024012523124504800_CIT0028","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1001\/jamainternmed.2013.14764","article-title":"Antihypertensive medications and serious fall injuries in a nationally representative sample of older adults","volume":"174","author":"Tinetti","year":"2014","journal-title":"JAMA Intern Med"},{"key":"2024012523124504800_CIT0029","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1001\/jamainternmed.2014.4520","article-title":"Risks and benefits of antihypertensive medications in older adults reply","volume":"174","author":"Tinetti","year":"2014","journal-title":"JAMA Intern Med"},{"key":"2024012523124504800_CIT0030","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1001\/jamainternmed.2014.4517","article-title":"Risks and benefits of antihypertensive medications in older adults","volume":"174","author":"Margolis","year":"2014","journal-title":"JAMA Intern Med"},{"key":"2024012523124504800_CIT0031","volume-title":"Protocol Version 4.0","author":"(SPRINT) SBPIT","year":"2012"},{"key":"2024012523124504800_CIT0032","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/jch.12281","article-title":"Trends in hypertension prevalence, awareness, treatment, and control among US adults 80 years and older, 1988\u20132010","volume":"16","author":"Bromfield","year":"2014","journal-title":"J Clin Hypertens"},{"key":"2024012523124504800_CIT0033","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1001\/jama.2010.650","article-title":"US trends in prevalence, awareness, treatment, and control of hypertension, 1988\u20132008","volume":"303","author":"Egan","year":"2010","journal-title":"JAMA"}],"container-title":["American Journal of Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajh\/article\/29\/6\/690\/2622390","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajh\/article\/29\/6\/690\/2622390","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,25]],"date-time":"2024-01-25T23:13:07Z","timestamp":1706224387000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajh\/article\/29\/6\/690\/2622390"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,4]]},"references-count":33,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2015,11,4]]},"published-print":{"date-parts":[[2016,6,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ajh\/hpv177","relation":{},"ISSN":["1941-7225","0895-7061"],"issn-type":[{"value":"1941-7225","type":"electronic"},{"value":"0895-7061","type":"print"}],"subject":[],"published-other":{"date-parts":[[2016,6]]},"published":{"date-parts":[[2015,11,4]]}}}